戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 that of the core of the regulatory domain of phenylalanine hydroxylase.
2 tor of the tetrahydropterin-dependent enzyme phenylalanine hydroxylase.
3 ss-react with either tyrosine hydroxylase or phenylalanine hydroxylase.
4 ormality in the function of the liver enzyme phenylalanine hydroxylase.
5 ading to competitive inhibition of epidermal phenylalanine hydroxylase.
6 h(enu2) mice have a mutation in the gene for phenylalanine hydroxylase.
7 ving, in most cases, a deficient activity of phenylalanine hydroxylase.
8 droxylase and the 122 N-terminal residues of phenylalanine hydroxylase.
9                                              Phenylalanine hydroxylase, a mononuclear non-heme iron e
10 th high levels of 6BH4, and the induction of phenylalanine hydroxylase activities during the telogen/
11 phenylalanine concentrations and we measured phenylalanine hydroxylase activity and phenylalanine int
12                                              Phenylalanine hydroxylase and 4a-hydroxy-6BH4-dehydratas
13 kinetic properties of pure recombinant human phenylalanine hydroxylase and on estimates of the in viv
14 mutations were incorporated into full-length phenylalanine hydroxylase and the complementary mutation
15                              Both the copper-phenylalanine hydroxylase and the copper-depleted hydrox
16  1 containing the C-terminal 331 residues of phenylalanine hydroxylase and the N-terminal 168 residue
17 ytic domains of the pterin-dependent enzymes phenylalanine hydroxylase and tyrosine hydroxylase are h
18 ordinates of two highly homologous proteins, phenylalanine hydroxylase and tyrosine hydroxylase, were
19 id hydroxylase family--tyrosine hydroxylase, phenylalanine hydroxylase, and tryptophan hydroxylase--r
20  tyrosine hydroxylase and of tyrosine 325 of phenylalanine hydroxylase are 5 and 4.5 A, respectively,
21 romatic amino acid hydroxylases tyrosine and phenylalanine hydroxylase both contain non-heme iron, ut
22 ional changes accompanying activation of rat phenylalanine hydroxylase by phenylalanine.
23                                              Phenylalanine hydroxylase catalyzes the first step in th
24 very pronounced asymmetry is observed in the phenylalanine hydroxylase, caused by the occurrence of t
25  hydroxylase locus using a full-length human phenylalanine hydroxylase cDNA clone as a hybridization
26 e site-specific genome integration of murine phenylalanine hydroxylase cDNA in the livers of phenylke
27 phage integration system, we delivered mouse phenylalanine hydroxylase cDNA to the livers of PKU mice
28                                 Tyrosine and phenylalanine hydroxylases contain homologous catalytic
29                                 The purified phenylalanine hydroxylase contains copper, which does no
30 e of the divergent Chromobacterium violaceum phenylalanine hydroxylase (CvPheOH) ( approximately 24%
31                        Phenylketonuria (PKU, phenylalanine hydroxylase deficiency), an inborn error o
32 H, the C-terminal 336 amino acid residues of phenylalanine hydroxylase; Delta155TYH, the C-terminal 3
33  induced by the inclusion of an inhibitor of phenylalanine hydroxylase, DL-p-chlorophenylalanine, and
34        Previous studies of ferrous wild-type phenylalanine hydroxylase, [Fe(2+)]PAH(T)[], have shown
35                    To study this hypothesis, phenylalanine hydroxylase from a bacterial source has be
36                     The non-heme iron enzyme phenylalanine hydroxylase from Chromobacterium violaceum
37                                              Phenylalanine hydroxylase from Chromobacterium violaceum
38                       Because defects in the phenylalanine hydroxylase gene (PAH) cause phenylketonur
39 ed within the protein coding sequence of the phenylalanine hydroxylase gene.
40 ive genetic disease caused by defects in the phenylalanine hydroxylase gene.
41                              A gene encoding phenylalanine hydroxylase has been cloned from Chromobac
42 he mouse liver by targeting it via the human phenylalanine hydroxylase (hPAH) gene promoter.
43 ne such interaction involves Tyr325 in human phenylalanine hydroxylase (hPAH), which forms a hydrogen
44 utations on the isolated catalytic domain of phenylalanine hydroxylase identified three residues that
45                                 In addition, phenylalanine hydroxylase is allosterically regulated by
46 he position corresponding to position 379 of phenylalanine hydroxylase is critical for dihydroxypheny
47                              In this context phenylalanine hydroxylase is subject to phosphorylation/
48  restriction site polymorphisms at the human phenylalanine hydroxylase locus among Caucasians are suc
49 ymorphisms have been identified at the human phenylalanine hydroxylase locus using a full-length huma
50  D4S1625 and D4S1629; and LOD = 2.56 at PAH (phenylalanine hydroxylase) on chromosome 12).
51 cture, dynamics, and function for the enzyme phenylalanine hydroxylase (PAH) can lead to needed new t
52                      The multi-domain enzyme phenylalanine hydroxylase (PAH) catalyzes the hydroxylat
53          MC-DNA vectors expressed the murine phenylalanine hydroxylase (Pah) complementary DNA (cDNA)
54 ave previously shown that the Fe(II) site in phenylalanine hydroxylase (PAH) converts from six-coordi
55                                              Phenylalanine hydroxylase (PAH) is a tetrahydrobiopterin
56 enylketonuria patients harboring a subset of phenylalanine hydroxylase (PAH) mutations have recently
57 -chain amino-acid transaminase 1 (BCAT1) and phenylalanine hydroxylase (PAH) with development of IFG.
58 th HPA harbor mutations in the gene encoding phenylalanine hydroxylase (PAH), and a small proportion
59 , inducible nitric oxide synthase (iNOS) and phenylalanine hydroxylase (PAH), and competition for BH4
60     Activated phenylalanine 4-monooxygenase, phenylalanine hydroxylase (PAH), is known to be involved
61 umans that arises from deficient activity of phenylalanine hydroxylase (PAH), which catalyzes the con
62                                              Phenylalanine hydroxylase (Pah)-deficient "PKU mice" hav
63 her PHS/DCoH could enhance the expression of phenylalanine hydroxylase (PAH).
64                     The regulatory domain of phenylalanine hydroxylase (PAH, EC ) consists of more th
65                    The activity of rat liver phenylalanine hydroxylase (PAH; phenylalanine 4-monooxyg
66 enase, the neural cell adhesion molecule L1, phenylalanine hydroxylase, paired box 6, the X-linked re
67                                              Phenylalanine hydroxylase (PheH) and tryptophan hydroxyl
68                                              Phenylalanine hydroxylase (PheH) catalyzes the key step
69                                    Mammalian phenylalanine hydroxylase (PheH) is an allosteric enzyme
70                                        Liver phenylalanine hydroxylase (PheH) is an allosteric enzyme
71                                              Phenylalanine hydroxylase (PheH) is an iron(II)-dependen
72 tyrosine hydroxylase (TyrH) whose homolog in phenylalanine hydroxylase (PheH) takes on a different co
73                                              Phenylalanine hydroxylase (PheOH) catalyzes the conversi
74                                   The enzyme phenylalanine hydroxylase (PheOH) catalyzes the hydroxyl
75 ry dehydratase, together with genes encoding phenylalanine hydroxylase (PhhA) and aromatic aminotrans
76 i and is hypothesized to be the cofactor for phenylalanine hydroxylase (PhhA) in Pseudomonas aerugino
77 ssess a cluster of structural genes encoding phenylalanine hydroxylase (PhhA), carbinolamine dehydrat
78 with Delta117PheH, the catalytic core of rat phenylalanine hydroxylase, ranging from 1.12-1.41.
79                               Only wild-type phenylalanine hydroxylase required pretreatment with phe
80                             This sequence in phenylalanine hydroxylase (residues 19 to 33) has previo
81                                              Phenylalanine hydroxylase stimulator (PHS) is a componen
82 rited disease caused by impaired activity of phenylalanine hydroxylase, the enzyme that converts phen
83  mutation of the corresponding valine 379 of phenylalanine hydroxylase to aspartate was not sufficien
84 ase to aspartate was not sufficient to allow phenylalanine hydroxylase to form dihydroxyphenylalanine
85                      The nonheme iron enzyme phenylalanine hydroxylase, tyrosine hydroxylase, and try
86                                              Phenylalanine hydroxylase, tyrosine hydroxylase, and try
87 the family of pterin-dependent hydroxylases, phenylalanine hydroxylase, tyrosine hydroxylase, and try
88 uncated and chimeric mutants of tyrosine and phenylalanine hydroxylase were constructed: Delta117PAH,
89  proteins containing the catalytic domain of phenylalanine hydroxylase were unable to hydroxylate tyr
90 ficity, seven residues in the active site of phenylalanine hydroxylase whose side chains are dissimil
91 f a recombinant adeno-associated virus-mouse phenylalanine hydroxylase-woodchuck hepatitis virus post

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。